Scarica l'app Stockscreener
23.93
3.48%
0.805
Precedente Chiudi:
$23.12
Aprire:
$23.36
Volume 24 ore:
14,114
Relative Volume:
0.25
Capitalizzazione di mercato:
$223.96M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-8.68%
1M Prestazione:
+9.50%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$22.40
$24.89
Intervallo di 1 settimana:
$22.40
$27.76
Portata 52W:
$15.80
$34.31
Tvardi Therapeutics Inc Stock (TVRD) Company Profile
Nome
Tvardi Therapeutics Inc
Settore
Industria
Telefono
(713) 489-8654
Indirizzo
3 SUGAR CREEK CTR. BLVD., SUGAR LAND
Confronta TVRD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TVRD
Tvardi Therapeutics Inc
|
23.93 | 225.97M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tvardi Therapeutics Inc Stock (TVRD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | Raymond James | Outperform |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | Piper Sandler | Overweight |
| 2025-05-21 | Iniziato | Oppenheimer | Outperform |
| 2025-05-15 | Iniziato | BTIG Research | Buy |
| 2024-06-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-06-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-06-13 | Downgrade | Needham | Buy → Hold |
| 2024-06-13 | Downgrade | Stifel | Buy → Hold |
| 2023-03-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-11-01 | Ripresa | Canaccord Genuity | Buy |
| 2021-08-03 | Iniziato | JP Morgan | Neutral |
| 2020-04-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-29 | Reiterato | Laidlaw | Buy |
| 2019-02-06 | Ripresa | Jefferies | Buy |
| 2019-01-15 | Iniziato | BofA/Merrill | Neutral |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Jefferies | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-06-28 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-12 | Ripresa | H.C. Wainwright | Buy |
| 2018-02-12 | Aggiornamento | Janney | Neutral → Buy |
| 2018-01-19 | Iniziato | Seaport Global Securities | Buy |
Mostra tutto
Tvardi Therapeutics Inc Borsa (TVRD) Ultime notizie
Can volume confirm reversal in Tvardi Therapeutics Inc.Buy/Sell Zone Confirmation Technical Analysis - Newser
Is Tvardi Therapeutics Inc. trending in predictive chart modelsForecasting Stock Moves with AI Insights - Newser
Is this a good reentry point in Tvardi Therapeutics Inc.Secure Buy Strategy Based on Risk Parameters - Newser
Top chart patterns to watch in Tvardi Therapeutics Inc.Real Time Trade Execution Alert Plan - Newser
How sentiment analysis helps forecast Tvardi Therapeutics Inc.Free Value Investing Picks With Stability - Newser
Will Tvardi Therapeutics Inc. stock go up soonFree Trend Following Strategy With Stop Loss - Newser
What high frequency data says about Tvardi Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser
Analyzing Tvardi Therapeutics Inc. with risk reward ratio chartsFree Alpha Driven Watchlist With Alerts - Newser
Volatility clustering patterns for Tvardi Therapeutics Inc.Historical Volatility and Pattern Breakdown Analysis - Newser
What machine learning models say about Tvardi Therapeutics Inc.Early Entry Planner for Swing Candidates - Newser
Building trade automation scripts for Tvardi Therapeutics Inc.Top Stock Picks with Forecast Accuracy - Newser
Is Tvardi Therapeutics Inc. meeting your algorithmic filter criteriaFree High Accuracy Alerts for ROI Traders - Newser
Can technical indicators confirm Tvardi Therapeutics Inc.’s reversalFree Technical Entry Strategy for Beginners - Newser
Published on: 2025-08-04 07:15:03 - metal.it
Does Tvardi Therapeutics Inc. stock perform well during market downturnsUnprecedented profits - Jammu Links News
Should I hold or sell Tvardi Therapeutics Inc. stock in 2025Build a winning investment portfolio - Jammu Links News
Tvardi Therapeutics Inc. Stock Analysis and ForecastGet alerts on high-potential market moves - Jammu Links News
How volatile is Tvardi Therapeutics Inc. stock compared to the marketGet high-impact stock recommendations now - Jammu Links News
Is Tvardi Therapeutics Inc. a good long term investmentInvest confidently with real-time updates - Jammu Links News
What is the risk reward ratio of investing in Tvardi Therapeutics Inc. stockRealize exceptional returns through smart trading - Jammu Links News
How institutional ownership impacts Tvardi Therapeutics Inc. stockDownside Control Plan With Support Analysis - Newser
How does Tvardi Therapeutics Inc. generate profit in a changing economyRapid wealth multiplication - Jammu Links News
What are analysts’ price targets for Tvardi Therapeutics Inc. in the next 12 monthsCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Tvardi Therapeutics Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
What catalysts could drive Tvardi Therapeutics Inc. stock higher in 2025Build wealth steadily with smart stock selection - Jammu Links News
What recovery options are there for Tvardi Therapeutics Inc.Watchlist Summary for Active Day Traders - Newser
Is Tvardi Therapeutics Inc. stock poised for growthDaily Market Momentum and Pressure Analysis - Newser
How to build a custom watchlist for Tvardi Therapeutics Inc.Free Risk Controlled Picks With Real Returns - Newser
Published on: 2025-07-31 10:29:26 - metal.it
Tvardi Therapeutics Inc Azioni (TVRD) Dati Finanziari
Non sono disponibili dati finanziari per Tvardi Therapeutics Inc (TVRD). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):